Low ARID1A expression improves the response to immunotherapy in EGFR-mutant lung adenocarcinoma

Sun et al. "ARID1A deficiency reverses the response to anti-PD(L)1 therapy in EGFR mutant lung adenocarcinoma by enhancing autophagy-inhibited type I interferon production." Cell Communication and Signaling (2022)
Read the article: doi.org/10.118...
Video produced by www.researchsqu...